Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Tania Perrone"'
Autor:
Andrea Anichini, Emilio Bajetta, Tania Perrone, Paola Morosini, Paola Queirolo, Davide Bedognetti, Mario R. Sertoli, Nicola Pimpinelli, Lorenza Di Guardo, Stefania Canova, Roberta Mortarini, Michele Del Vecchio
Purpose: To assess the clinical and biological activity of the association of bevacizumab and fotemustine as first-line treatment in advanced melanoma patients.Experimental Design: Previously untreated, metastatic melanoma patients (n = 20) received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11383125cc26b59bf18cbaad15ca79f6
https://doi.org/10.1158/1078-0432.c.6519213
https://doi.org/10.1158/1078-0432.c.6519213
Autor:
Andrea Anichini, Emilio Bajetta, Tania Perrone, Paola Morosini, Paola Queirolo, Davide Bedognetti, Mario R. Sertoli, Nicola Pimpinelli, Lorenza Di Guardo, Stefania Canova, Roberta Mortarini, Michele Del Vecchio
Supplementary Figures S1-S3 and Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1078b265dc877bc41214f98aef205adb
https://doi.org/10.1158/1078-0432.22442499.v1
https://doi.org/10.1158/1078-0432.22442499.v1
Autor:
Francesca Scolari, Francesco Mannelli, Tania Perrone, Giacomo Gianfaldoni, Rosa Fanci, Barbara Scappini, Luigi Rigacci, Erminio Bonizzoni, Davide Croce, Alberto Bosi, Rolando Innocenti, Umberto Restelli
Publikováno v:
Journal of Blood Medicine
Rolando Innocenti,1 Luigi Rigacci,1,2 Umberto Restelli,3,4 Barbara Scappini,1 Giacomo Gianfaldoni,1 Rosa Fanci,1 Francesco Mannelli,1 Francesca Scolari,3 Davide Croce,3,4 Erminio Bonizzoni,5 Tania Perrone,6 Alberto Bosi1 1Hematology Department, Unive
Autor:
Rolando Innocenti, Luigi Rigacci, Umberto Restelli, Barbara Scappini, Giacomo Gianfaldoni, Rosa Fanci, Francesco Mannelli, Francesca Scolari, Davide Croce, Erminio Bonizzoni, Tania Perrone, Alberto Bosi
Publikováno v:
Journal of Blood Medicine. 10:69-70
Innocenti R, Rigacci L, Restelli U, et al J Blood Med. 2019;10:21–27.On page 24, Figure 2, the key for the figure was incorrect. Read the original article
Autor:
Alberto Farina, Erminio Bonizzoni, Tania Perrone, Dan Seiler, Augusto Caraceni, Ernesto Zecca, Andrea Manzoni, Fabio Centurioni
Publikováno v:
British Journal of Clinical Pharmacology
Aims Transdermal fentanyl is a well established treatment for cancer pain. The aim of the present study is to assess the relative bioavailability of fentanyl from two different transdermal systems by evaluating plasma drug concentrations after single
Autor:
Laura Ottino, Nicoletta Biglia, Marta D'Alonzo, Valentina Elisabetta Bounous, Elisabetta Robba, Valentina Tuninetti, Tania Perrone
Publikováno v:
Clinical breast cancer. 17(8)
Background Vulvovaginal atrophy (VVA) is a relevant problem for breast cancer survivors (BCSs), in particular for those who receive aromatase inhibitors (AIs). We conducted a survey, to assess the attitude of oncologists toward the diagnosis and trea
Autor:
Sofia Kovalchuk, Elisa Fabbri, Tania Perrone, Erminio Bonizzoni, Alberto Bosi, Luigi Rigacci, Benedetta Puccini
Publikováno v:
Supportive Care in Cancer
Purpose The risk of febrile neutropenia (FN) in cancer patients receiving chemotherapy is mainly due to the type of chemotherapy regimen and the presence of specific risk factors in patients. The recent trend of using a dose-dense treatment schedule
Autor:
Tania Perrone, Matti Aapro, Luigi Celio, Silvia Sebastiani, Erminio Bonizzoni, Emilio Bajetta
Publikováno v:
Supportive Care in Cancer
Purpose Data from two randomized trials, evaluating a single-day regimen of palonosetron plus dexamethasone against emesis due to moderately emetogenic chemotherapy, were assessed for the impact of age on outcome in a pooled sample of women receiving
Autor:
Marianna Giampaglia, Tania Perrone, L. Petrucelli, Valeria Saracino, Vito Lorusso, Antonio Gnoni
Publikováno v:
Supportive Care in Cancer
Introduction The goal of pharmacological prophylaxis of chemotherapy-induced nausea and vomiting (CINV) should be the elimination of both nausea and vomiting symptoms during all planned chemotherapy cycles. The aim of this study was to assess the eff
Autor:
Renato Alterini, Luigi Rigacci, Valentina Carrai, Benedetta Puccini, Alberto Bosi, Jean Pierre Caruso, Tania Perrone, Carla Landi
Publikováno v:
Leukemia Research. 36:182-185
To evaluate the efficacy of a new agent, palonosetron, in Hodgkin Lymphoma patients treated with ABVD regimen. Complete response during the overall phase of the first ABVD cycle, was the primary endpoint. Secondary end points were: emesis-free patien